19Indexed trials
drug · Product Intelligence
Risperidone
Pipeline Intelligence
Risperidone: 19 indexed trials, 18 sponsors; 6 linked Orange Book patents and 8 FDA-linked events where matched.
18Sponsors
6Orange Book patent links
8FDA-linked events
Development evidence
NCT00034762Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · alzheimersPHASE3
NCT00044655Icahn School of Medicine at Mount Sinai · schizophreniaPHASE4
NCT00103727GlaxoSmithKline · schizophreniaPHASE2
NCT00190749Eli Lilly and Company · schizophreniaPHASE4
NCT00206102AstraZeneca · schizophreniaPHASE4
NCT00222495University of Minnesota · schizophreniaNA
NCT00236444Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · adhdPHASE3
NCT00261508Janssen-Ortho Inc., Canada · autismPHASE3
NCT00297739Armenteros, Jorge L., M.D., P.A. · adhdPHASE4
NCT00594269Sykehuset Innlandet HF · depressionPHASE4
NCT00746252University of Maryland, Baltimore · bipolar_disorderNA
NCT01175135Pfizer · schizophreniaPHASE2
NCT01185418Chonbuk National University Hospital · schizophreniaCOMPLETED
NCT02462473Janssen Research & Development, LLC · schizophreniaPHASE2
NCT02532491Fundación Marques de Valdecilla · schizophreniaPHASE4
FDA / patent evidence
12329851UZEDY · app 2135862042-03-17
12128132UZEDY · app 2135862040-09-11
12383493UZEDY · app 2135862040-09-11
9023897UZEDY · app 2135862033-04-05
8221778UZEDY · app 2135862027-11-12
8741327UZEDY · app 2135862027-11-12
Regulatory context
FDA_EXCLUSIVITYUZEDY · NP2026-04-28
FDA_APPROVALUZEDY · 2023-04-28
FDA_APPROVALRISPERIDONE · 2013-02-12
FDA_APPROVALRISPERIDONE · 2011-04-19
FDA_APPROVALRISPERIDONE · 2010-08-06
FDA_APPROVALRISPERIDONE · 2009-07-29
FDA_APPROVALRISPERIDONE · 2009-03-23
FDA_APPROVALRISPERIDONE · 2008-12-05
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.